Edris, Jainodin D.
HRN: 23 12 60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CEFTRIAXONE 1G (VIAL)
05/31/2023
06/06/2023
IV
2gm
OD
Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes